Saturday 17 October 2026
Export HTFL’s income statement to Excel — free account
Heartflow, Inc.
HTFL Healthcare Health Information Services
Heartflow, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $176.0 million, up 39.9% from fiscal 2024. In the quarter to June 2026, revenue grew 47.6%, EPS grew 87.7% and free cash flow grew 62.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
48.29
2.62
−5.15%
Follow HTFL
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+7 more quarters Free account |
P/S ratio |
11.95 | 10.89 | 6.10 | 10.21 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(295.55) | (69.21) | (101.39) | (558.99) | |
P/B ratio |
9.06 | 7.29 | 3.57 | 6.49 | |
Price to Tangible BV |
9.06 | 7.29 | 3.57 | 6.49 | |
EV/Sales |
12.05 | 11.01 | 6.13 | 9.54 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(48.91) | (29.70) | (19.99) | (26.87) | |
EV/FCF |
(43.17) | (27.45) | (18.29) | (25.35) | |
Quick Ratio |
4.66 | 5.10 | 4.87 | 8.43 | |
Current Ratio |
5.08 | 5.57 | 5.20 | 8.66 | |
Net Debt/EBITDA |
10.01 | 5.67 | 10.29 | 25.52 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.84 | 0.72 | 0.74 | 0.59 | |
Operating CF/Net income |
0.54 | 1.10 | 0.43 | 0.06 | |
Capex/Depreciation |
(1.16) | (1.18) | (3.33) | (0.33) | |
Interest Coverage |
— | (9,834.67) | (2,218.75) | (4.38) | |
Research and Development Expense of Revenue |
40.98% | 41.11% | 37.99% | 37.38% | |
Selling, General and Administrative Expense of Revenue |
69.96% | 80.94% | 77.65% | 71.78% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
12.35% | 12.46% | 10.71% | 8.56% | |
Graham Net Nets |
0.06 | 0.07 | 0.15 | 0.13 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(6.24%) | (12.78%) | (27.57%) | (39.83%) | |
Free Cash Flow Yield |
(2.33%) | (3.68%) | (5.50%) | (3.69%) | |
Revenue per Share |
0.74 | 0.61 | 1.33 | 0.94 | |
Operating CF per Share |
(0.10) | (0.35) | (0.29) | (0.06) | |
Capex per Share |
(0.02) | (0.02) | (0.05) | (0.03) | |
Free Cash Flow per Share |
(0.12) | (0.37) | (0.34) | (0.09) | |
Cash per Share |
1.88 | 1.85 | 4.80 | 5.93 | |
Shareholders Equity per Share |
3.24 | 3.34 | 8.16 | 5.18 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.24 | 3.34 | 8.16 | 5.18 | |
Free Cash Flow |
(10.50) | (31.99) | (12.49) | (4.19) | |
Working Capital |
179.88 | 173.81 | 177.83 | 289.94 | |
Capital Expenditures |
(1.92) | (1.89) | (1.90) | (1.23) | |
Net Current Asset Value |
159.23 | 153.52 | 161.40 | 217.96 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.03 | 0.04 | 0.04 | 0.03 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
36.22 | 31.92 | 26.99 | 24.20 | |
Average Payables |
3.36 | 3.86 | 3.02 | 2.42 | |
Average Assets |
251.91 | 264.23 | 239.08 | 274.72 | |
Average Common Equity |
(307.53) | (301.64) | (279.42) | (261.50) |
Columns are period end dates